Development of multi-modal small-molecule theranostic agents including PET, SPECT, fluorescence, MRI, and CT to achieve seamless integration of precision diagnosis and therapy.
Establishing in vivo imaging-based methods for rapid and high-throughput screening of therapeutics against complex diseases with unclear pathological mechanisms.
Engineering novel full-spectrum, wide-field, mesoscopic, and microscopic in vivo fluorescence imaging systems, coupled with advanced image analysis algorithms.
Imaging setup
Imaging processing algorithm
Probe
Leading compounds
Target/mechanism identification
Pharmacodynamic evaluations
Meet the multidisciplinary researchers behind our work and explore our latest publications pushing the boundaries of molecular imaging and theranostics.
